Anti-inflammatory and immunomodulative effects of human recombinant thrombomodulin for severe septic patients

Anti-inflammatory and immunomodulative effects of human recombinant thrombomodulin for severe septic patients - Anti-inflammatory and immunomodulative effects of human recombinant thrombomodulin

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018868

Enrollment

Registered

2015-08-31

Start date

2015-08-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe sepsis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Severe sepsis with DIC patients hospitalized tokai university hospital.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
lymphocyte number DIC score Cytokine levels	—

Secondary

Measure	Time frame
Mortality (28, 90, ICU, in-hospital) ventilator days	—

Countries

Japan

Contacts

Public ContactShigeaki Inoue

Tokai University, School of Medicine Dept. of Emergency and Critical Care Medicine

sg-inoue@is.icc.u-tokai.ac.jp0463-93-1121

Outcome results